Vertex ' s Triple Combo Cystic-fibrosis Drug Meets Main Late-stage Study Goals Vertex ' s Triple Combo Cystic-fibrosis Drug Meets Main Late-stage Study Goals

Vertex Pharmaceuticals ' experimental cystic-fibrosis treatment met all of its main goals in a late-stage study when tested in patients aged 12 years and older, the company...Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine Source Type: news